AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-96
Results: 1-25/96
PLATELETS RELEASE LAMBDA-GRANULES (LYSOSOMES) IN-VIVO IN HUMANS UPON ACTIVATION
Authors: CIFERRI S ORLACCHIO A GUGLIELMINI C DEIOANNI M EMILIANI C NENCI GG GRESELE P
Citation: S. Ciferri et al., PLATELETS RELEASE LAMBDA-GRANULES (LYSOSOMES) IN-VIVO IN HUMANS UPON ACTIVATION, Thrombosis research, 91(3), 1998, pp. 36-36
UPPER EXTREMITY DEEP-VEIN THROMBOSIS - RISK-FACTORS AND EMBOLIC COMPLICATIONS
Authors: VERSO M AGNELLI G NENCI GG
Citation: M. Verso et al., UPPER EXTREMITY DEEP-VEIN THROMBOSIS - RISK-FACTORS AND EMBOLIC COMPLICATIONS, Thrombosis research, 91(3), 1998, pp. 88-88
COMBINED EFFECT OF OBESITY AND NIDDM ON SOME HEMOSTATIC PARAMETERS
Authors: PARISE P BIGARONI A FELICI D PERRIELLO G BRUNETTI P NENCI GG
Citation: P. Parise et al., COMBINED EFFECT OF OBESITY AND NIDDM ON SOME HEMOSTATIC PARAMETERS, Thrombosis research, 91(3), 1998, pp. 108-108
IN-VITRO GENE TRANSFECTION OF ENDOTHELIAL-CELLS WITH NONVIRAL VECTORS- EVALUATION OF TRANSFECTION EFFICIENCY USING DIFFERENT CATIONIC LIPOSOMES
Authors: COSTANTINI V ALLEGRUCCI M PAOLUCCI MC RICCI M DEVEGLIA R PRESILLA MC NENCI GG
Citation: V. Costantini et al., IN-VITRO GENE TRANSFECTION OF ENDOTHELIAL-CELLS WITH NONVIRAL VECTORS- EVALUATION OF TRANSFECTION EFFICIENCY USING DIFFERENT CATIONIC LIPOSOMES, Thrombosis research, 91(3), 1998, pp. 159-159
EVALUATION OF PHARMACOKINETIC AND ANTITHROMBOTIC ACTIVITY OF UNFRACTIONED HEPARIN (UFH) AFTER INTRADUODENAL ADMINISTRATION IN RATS
Authors: COSTANTINI V DEVEGLIA R STABILE A NENCI GG
Citation: V. Costantini et al., EVALUATION OF PHARMACOKINETIC AND ANTITHROMBOTIC ACTIVITY OF UNFRACTIONED HEPARIN (UFH) AFTER INTRADUODENAL ADMINISTRATION IN RATS, Thrombosis research, 91(3), 1998, pp. 270-270
PROGNOSTIC IMPACT OF TISSUE CONCENTRATION OF UROKINASE (UPA), ITS RECEPTOR (UPAR), AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) ON THE SURVIVAL OF PATIENTS WITH BREAST-CANCER - A PROSPECTIVE-STUDY
Authors: COSTANTINI V CAZZATO AO PASQUALINI ME DEMONTE P VIENNA L MARIOTTI M DEVEGLIA R TONATO M NENCI GG
Citation: V. Costantini et al., PROGNOSTIC IMPACT OF TISSUE CONCENTRATION OF UROKINASE (UPA), ITS RECEPTOR (UPAR), AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) ON THE SURVIVAL OF PATIENTS WITH BREAST-CANCER - A PROSPECTIVE-STUDY, Thrombosis research, 91(3), 1998, pp. 273-273
ACTIVATED HUMAN PROTEIN-C PREVENTS THROMBIN-INDUCED THROMBOEMBOLISM IN MICE - EVIDENCE THAT ACTIVATED PROTEIN-C REDUCES INTRAVASCULAR FIBRIN ACCUMULATION THROUGH THE INHIBITION OF ADDITIONAL THROMBIN GENERATION
Authors: GRESELE P MOMI S BERRETTINI M NENCI GG SCHWARZ HP SEMERARO N COLUCCI M
Citation: P. Gresele et al., ACTIVATED HUMAN PROTEIN-C PREVENTS THROMBIN-INDUCED THROMBOEMBOLISM IN MICE - EVIDENCE THAT ACTIVATED PROTEIN-C REDUCES INTRAVASCULAR FIBRIN ACCUMULATION THROUGH THE INHIBITION OF ADDITIONAL THROMBIN GENERATION, The Journal of clinical investigation, 101(3), 1998, pp. 667-676
REGULATION OF PLATELET PHOSPHOLIPASE-A2 (PLA2) ACTIVATION - ROLE OF CALCIUM AND PROTEIN-KINASE-C (PKC)
Authors: NUCCIARELLI F GRESELE P NARDICCHI V IORIO P BARTOLINI S NENCI GG GORACCI G
Citation: F. Nucciarelli et al., REGULATION OF PLATELET PHOSPHOLIPASE-A2 (PLA2) ACTIVATION - ROLE OF CALCIUM AND PROTEIN-KINASE-C (PKC), Thrombosis and haemostasis, 1997, pp. 1080-1080
FIXED-DOSE OF LMWH REVIPARIN IS MORE EFFECTIVE THAN ADJUSTED-DOSE OF UH IN INHIBITING THROMBIN GENERATION IN PATIENTS AT RISK OF THROMBOEMBOLISM
Authors: PARISE P ASCANI A MORINI M BIGARONI A ZANUTTINI F NENCI GG
Citation: P. Parise et al., FIXED-DOSE OF LMWH REVIPARIN IS MORE EFFECTIVE THAN ADJUSTED-DOSE OF UH IN INHIBITING THROMBIN GENERATION IN PATIENTS AT RISK OF THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 1165-1165
COMPASSIONATE USE OF DERMATAN SULFATE IN PATIENTS WITH CONTRAINDICATIONS TO HEPARIN
Authors: TALIANI MR AGNELLI G SONAGLIA F GIANESE F NENCI GG
Citation: Mr. Taliani et al., COMPASSIONATE USE OF DERMATAN SULFATE IN PATIENTS WITH CONTRAINDICATIONS TO HEPARIN, Thrombosis and haemostasis, 1997, pp. 1179-1179
DIABETES-MELLITUS, HYPERCHOLESTEROLEMIA AND HYPERTENSION, BUT NOT VASCULAR-DISEASE PER SE, ARE ASSOCIATED WITH PERSISTENT PLATELET ACTIVATION IN-VIVO - EVIDENCE DERIVED FROM THE STUDY OF PERIPHERAL ARTERIAL-DISEASE
Authors: DAVI G GRESELE P VIOLI F BASILI S CATALANO M GIAMMARESI C VOLPATO R NENCI GG CIABATTONI G PATRONO C
Citation: G. Davi et al., DIABETES-MELLITUS, HYPERCHOLESTEROLEMIA AND HYPERTENSION, BUT NOT VASCULAR-DISEASE PER SE, ARE ASSOCIATED WITH PERSISTENT PLATELET ACTIVATION IN-VIVO - EVIDENCE DERIVED FROM THE STUDY OF PERIPHERAL ARTERIAL-DISEASE, Thrombosis and haemostasis, 1997, pp. 1575-1575
THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PATIENTS RECEIVING PROPHYLACTIC ANTITHROMBOTIC REGIMENS WITH UNFRACTIONED HEPARIN OR LMWH (REVIPARIN)
Authors: BERRETTINI M ASCANI A PARISE P MORINI M MALASPINA M ZANUTTINI F NENCI GG
Citation: M. Berrettini et al., THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PATIENTS RECEIVING PROPHYLACTIC ANTITHROMBOTIC REGIMENS WITH UNFRACTIONED HEPARIN OR LMWH (REVIPARIN), Thrombosis and haemostasis, 1997, pp. 1674-1674
HUMAN BLOOD-PLATELETS RELEASE THEIR LYSOSOMAL CONTENT IN-VIVO AT A LOCALIZED SITE OF PLATELET ACTIVATION
Authors: CIFERRI S EMILIANI C ORLACCHIO A NENCI GG GRESELE P
Citation: S. Ciferri et al., HUMAN BLOOD-PLATELETS RELEASE THEIR LYSOSOMAL CONTENT IN-VIVO AT A LOCALIZED SITE OF PLATELET ACTIVATION, Thrombosis and haemostasis, 1997, pp. 1976-1976
INCREASED PLASMA-LEVELS OF HOMOCYSTEINE IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
Authors: BERRETTINI M AVERSA F RUFINI S RUGGERI L LUCARELLI G MARTELLI MF NENCI GG
Citation: M. Berrettini et al., INCREASED PLASMA-LEVELS OF HOMOCYSTEINE IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION, Thrombosis and haemostasis, 1997, pp. 2166-2166
CYTOSOLIC AND MEMBRANE-BOUND UROKINASE RECEPTOR, UROKINASE AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 EVALUATED IN NON-DETERGENT EXTRACTS OF 192BREAST CARCINOMAS
Authors: COSTANTINI V CAZZATO AO PASQUALINI ME DEMONTE P VIENNA L MARIOTTI M DEVEGLIA R TONATO M NENCI GG
Citation: V. Costantini et al., CYTOSOLIC AND MEMBRANE-BOUND UROKINASE RECEPTOR, UROKINASE AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 EVALUATED IN NON-DETERGENT EXTRACTS OF 192BREAST CARCINOMAS, Thrombosis and haemostasis, 1997, pp. 2268-2268
REDUCTION OF CIRCULATING PAI-1 BY ACTIVATED HUMAN PROTEIN-C IN MICE -NO EVIDENCE FOR PAI-1 INACTIVATION
Authors: COLUCCI M NASIMI M MOMI S SCOPECE S SEMERARO N NENCI GG GRESELE P
Citation: M. Colucci et al., REDUCTION OF CIRCULATING PAI-1 BY ACTIVATED HUMAN PROTEIN-C IN MICE -NO EVIDENCE FOR PAI-1 INACTIVATION, Thrombosis and haemostasis, 1997, pp. 2437-2437
PLATELET ACTIVATION MARKERS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE - A PROSPECTIVE COMPARISON OF DIFFERENT PLATELET-FUNCTION TESTS
Authors: GRESELE P CATALANO M GIAMMARRESI C VOLPATO R TERMINI R CIABATTONI G NENCI GG DAVI G
Citation: P. Gresele et al., PLATELET ACTIVATION MARKERS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE - A PROSPECTIVE COMPARISON OF DIFFERENT PLATELET-FUNCTION TESTS, Thrombosis and haemostasis, 78(6), 1997, pp. 1434-1437
EFFECT OF DERMATAN SULFATE ON ACTIVATED PARTIAL THROMBOPLASTIN TIME DETERMINED WITH DIFFERENT REAGENTS
Authors: IORIO A NUCCIARELLI F RENGA C NENCI GG GIANESE F AGNELLI G
Citation: A. Iorio et al., EFFECT OF DERMATAN SULFATE ON ACTIVATED PARTIAL THROMBOPLASTIN TIME DETERMINED WITH DIFFERENT REAGENTS, Haemostasis, 27(2), 1997, pp. 85-90
DIABETES-MELLITUS, HYPERCHOLESTEROLEMIA, AND HYPERTENSION BUT NOT VASCULAR-DISEASE PER SE ARE ASSOCIATED WITH PERSISTENT PLATELET ACTIVATION IN-VIVO - EVIDENCE DERIVED FROM THE STUDY OF PERIPHERAL ARTERIAL-DISEASE
Authors: DAVI G GRESELE P VIOLI F BASILI S CATALANO M GIAMMARRESI C VOLPATO R NENCI GG CIABATTONI G PATRONO C
Citation: G. Davi et al., DIABETES-MELLITUS, HYPERCHOLESTEROLEMIA, AND HYPERTENSION BUT NOT VASCULAR-DISEASE PER SE ARE ASSOCIATED WITH PERSISTENT PLATELET ACTIVATION IN-VIVO - EVIDENCE DERIVED FROM THE STUDY OF PERIPHERAL ARTERIAL-DISEASE, Circulation, 96(1), 1997, pp. 69-75
LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY
Authors: BARBUI T DEGAETANO G FINAZZI G LANDOLFI R MARCHIOLI R PATRONO C TOGNONI G CAPANI F DECARLI A GAMBI D NENCI GG TURA S MANDELLI F ROSSIFERRINI P CORTELAZZO S VESTRI O FINELLI C NOCENTINI F POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGILIONE R ANGELI G DIBLASIO A DIPASQUALE A KRAMER V MARFISI RM OLIVIERI M SCIULLI L SPOLTORE R MONTEFUSCO E SPADEA A CAROTENUTO M NOBILE M MORELLI A RESEGOTTI L VASINO MAC RODEGHIERO F RUGGERI M
Citation: T. Barbui et al., LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY, British Journal of Haematology, 97(2), 1997, pp. 453-456
POST DISCHARGE CLINICALLY OVERT VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY PATIENTS WITH NEGATIVE VENOGRAPHY AN OVERVIEW ANALYSIS
Authors: RICOTTA S IORIO A PARISE P NENCI GG AGNELLI G
Citation: S. Ricotta et al., POST DISCHARGE CLINICALLY OVERT VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY PATIENTS WITH NEGATIVE VENOGRAPHY AN OVERVIEW ANALYSIS, Thrombosis and haemostasis, 76(6), 1996, pp. 887-892
INCREASED PLASMA-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AFTER N-3 POLYUNSATURATED FATTY-ACIDS SUPPLEMENTATION IN PATIENTS WITH CHRONIC ATHEROSCLEROTIC DISEASE
Authors: BERRETTINI M PARISE P RICOTTA S IORIO A PEIRONE C NENCI GG
Citation: M. Berrettini et al., INCREASED PLASMA-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AFTER N-3 POLYUNSATURATED FATTY-ACIDS SUPPLEMENTATION IN PATIENTS WITH CHRONIC ATHEROSCLEROTIC DISEASE, Thrombosis and haemostasis, 75(3), 1996, pp. 395-400
DISTRIBUTION AND OCCLUSIVENESS OF THROMBI IN PATIENTS WITH SURVEILLANCE DETECTED DEEP-VEIN THROMBOSIS AFTER HIP-SURGERY
Authors: ASCANI A RADICCHIA S PARISE P NENCI GG AGNELLI G
Citation: A. Ascani et al., DISTRIBUTION AND OCCLUSIVENESS OF THROMBI IN PATIENTS WITH SURVEILLANCE DETECTED DEEP-VEIN THROMBOSIS AFTER HIP-SURGERY, Thrombosis and haemostasis, 75(2), 1996, pp. 239-241
POSTDISCHARGE DEEP-VEIN THROMBOSIS AFTER ORTHOPEDIC-SURGERY
Authors: AGNELLI G IORIO A RICOTTA S PARISE P NENCI GG
Citation: G. Agnelli et al., POSTDISCHARGE DEEP-VEIN THROMBOSIS AFTER ORTHOPEDIC-SURGERY, Lancet, 348(9035), 1996, pp. 1180-1180
PROTEIN-KINASE-C INHIBITORS ENHANCE G-PROTEIN INDUCED PHOSPHOLIPASE A(2) ACTIVATION IN INTACT HUMAN PLATELETS
Authors: IORIO P GRESELE P STASI M NUCCIARELLI F VEZZA R NENCI GG GORACCI G
Citation: P. Iorio et al., PROTEIN-KINASE-C INHIBITORS ENHANCE G-PROTEIN INDUCED PHOSPHOLIPASE A(2) ACTIVATION IN INTACT HUMAN PLATELETS, FEBS letters, 381(3), 1996, pp. 244-248
Risultati: 1-25 | 26-50 | 51-75 | 76-96